Back to search

Article

An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain

2020-07-27

Abstract excerpt

<h4>ABSTRACT</h4> IGHV3-53-encoded neutralizing antibodies are commonly elicited during SARS-CoV-2 infection and target the receptor-binding domain (RBD) of the spike (S) protein. Such IGHV3-53 antibodies generally have a short CDR H3 due to structural constraints in binding the RBD (mode A). However, a small subset of IGHV3-53 antibodies to the RBD contain a longer CDR H3. Crystal structures of two IGHV3-53 neut...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
73b8b1f6-68e7-50f7-8c86-ac5e02a6f9f5
DOI
10.1101/2020.07.26.222232
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domainDOI 10.1101/2020.07.26.222232
Select a neighboring publication to make it the new centre.